Seeking Alpha

Q32 Bio Announces FDA Fast Track Designation Granted to Bempikibart (ADX-914) for the Treatment of Alopecia Areata

WALTHAM, Mass., April 30, 2025 /PRNewswire/ -- Q32 Bio Inc. (QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other ...
Morningstar

MavriX Bio Receives FDA Fast Track Designation for MVX-220 for Treatment of Angelman Syndrome

MIDDLETON, Mass., Sept. 22, 2025 /PRNewswire/ -- MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today ...
Seeking Alpha

Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch

NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...
Nasdaq

Intelligent Bio On Track To Seek FDA Clearance For Fingerprint Drug Test

(RTTNews) - Intelligent Bio Solutions Inc. (INBS), a medical technology company, today, announced that it is on track to make an FDA 510(k) submission for its Intelligent Fingerprinting Drug Screening ...
Morningstar

Leadpoint System to Showcase "BioTrack" at CES 2026, Delivering Verifiable AI to Complete Logistics Data "Track-Proof-Sustain"

Live demo at LVCC North Hall Booth #9013 (INCHEON–IFEZ Pavilion) unifies real-time pharmaceutical supply chain tracking, AI-driven operational insights, blockchain integrity verification, and an ...